Soaring Drug Prices Raise Tough Questions

Last month, shares of Valeant Pharmaceuticals tumbled after reports emerged alleging that the drugmaker uses a specialty mail-order pharmacy to prop up sales of its costly drugs. Though the company has since announced that the pharmacy will shut down, the damage was done. It’s the latest black eye for an industry that is already under intense scrutiny o…